WELL — WELL Health Technologies Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual income statement for WELL Health Technologies, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	50.2	302	569	776	920
Cost of Revenue
Gross Profit	21.2	154	303	372	363
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	62.5	321	525	761	975
Operating Profit	-12.3	-18.4	44.3	15.3	-54.9
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-7.57	-25.5	17.5	19.5	8.99
Provision for Income Taxes
Net Income After Taxes	-3.21	-31.3	18.7	16.6	29.1
Minority Interest
Net Income Before Extraordinary Items
Net Income	-3.69	-44.2	1.37	0.082	32.6
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-3.69	-44.2	1.37	0.082	32.6
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.003	-0.18	-0.048	0.096	0.187